Quick answers
- What is Garzulys?
- Garzulys is a brand name of Insulin aspart, a prescription medicine. The FDA NDC Directory lists 2 Garzulys products in 2 strengths and forms.
- Who makes Garzulys?
- Emerge Bioscience Pte. Ltd. holds the FDA application for Garzulys (BLA761497, approved July 24, 2026).
- Is there a generic or store brand of Garzulys?
- Yes. The FDA NDC Directory lists 46 other products with the same active ingredients, strength and form as a Garzulys product. Ask your pharmacist whether one is right for you.
- Has Garzulys been recalled?
- No recall linked to Garzulys products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Garzulys is
Each Garzulys product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Insulin aspart · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| insulin aspart 100 units/mL injection, solution (subcutaneous) | Garzulys | 23 products, 6 companies | DailyMed |
| insulin aspart 100 units/mL injection, solution (intravenous, subcutaneous) | Garzulys | 23 products, 6 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Insulin aspart →
FDA approval
- BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| BLA761497 | Emerge Bioscience Pte. Ltd. | July 24, 2026 | 2 |
Companies that list Garzulys
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Garzulys products.
- Meitheal Pharmaceuticals Inc.2 products
Recalls
No recall linked to Garzulys products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.